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z.2013.07Abstract The equine inﬂuenza (EI) is a highly contagious respiratory viral disease of equines. The
aim of the present study was to determine the amino acid mutation sequences of the partial nucle-
oprotein (NP), which includes four epitopes of the equine leucocyte antigen (ELA) of A/equine/
Nador/1/1997 (H3N8). These epitopes are critical for their binding to major histocompatibility
molecule complex (MHC) class I and recognition by speciﬁc Cytotoxic T Lymphocytes (CTLs).
The isolate was subjected to RT-PCR ampliﬁcations followed by sequencing analysis. Phylogenetic
analysis showed that Moroccan isolate belongs to equine host-speciﬁc lineage and more closely
related to Italian strains A/equine/Rome/5/1991 and A/equine/Italy/1062/1991. Amino acid
sequence comparison of the NP showed that the strain A/equine/Nador/1/1997 has twelve substi-
tutions at the residues T/284/A, A/286/T, R/293/K, I/299/V, V/312/I, N/319/K, S/344/L, V/353/
I, M/374/I, C/377/N, N/397/S and R/452/K. All substitutions concerned both the interaction
domains NP–NP and NP–PB2. However, the mutation N319 K enhances the NP–PB2 interaction
and polymerase activity in mammalian infected cells. S/344/L mutation was located on the FED-
LRVSNFI epitope (aa 338–347), this substitution is likely to help the virus to overcome the barrier
of cell-mediated immunity of the host. The identiﬁed mutations were grouped into two groups,
one included residues that facilitate the adaptation and evolution of inﬂuenza viruses within the
equine lineage such as A/286/T, R/293/K, S/344/L, V/353/I and R/452/K, while the second
contained the substitutions which enhance the virulence as polymerase activity (N319 K) and muta-boratory of Virology, Micro-
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CTLs (S/344/L).
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Equine inﬂuenza is an infectious and contagious disease of the
upper respiratory tract of horses, donkeys and their cross
products (Barquero et al., 2007; Gurkirpal, 1997). Two distinct
subtypes of equine inﬂuenza viruses were identiﬁed: A/equine/
Prague/1/56 prototypes (H7N7) and A/equine/Miami/1/63
(H3N8) (Sovinova et al., 1958; Waddell et al., 1963). These
viruses are a member of the family Orthomyxovirus (Ortho-
myxoviridae), which consists of eight single-stranded viral
RNA segments of negative polarity encoding a total of 11 pro-
teins (Zhirnov et al., 2009). Among these genes, the NP gene
(segment 5) plays a critical role in the species barrier and host
adaptation of inﬂuenza A viruses (Bean, 1984; Gorman et al.,
1990; Xu et al., 2011). These genomic RNAs are incorporated
into virions as ribonucleoprotein (RNP) complexes, which
consist of the viral RNA (vRNA) associated with three viral
polymerase subunit proteins (PA, PB1, and PB2) and nucleo-
protein (NP) (Li et al., 2009). The ribonucleoprotein complex
(RNP) is essential for the transcription and replication of the
genome in the cellular nucleus (Klumpp et al., 1997; Voeten
et al., 2000).Comma
Nucleoprotein, comprises a sequence of 498 amino acids, in
which the oligomerization is mediated by the insertion of the
structurally conserved tail loop (aa 402–428) of one NP mole-
cule to a groove of another NP (Ng et al., 2012).
The NP sequence is highly conserved among inﬂuenza virus
types and subtypes (Tarus et al., 2012). It contains a binding
region of the viral RNA to its N-terminus (residues 1–181),
two areas are responsible for auto-interaction NP–NP (resi-
dues 189–358 and 371–465) (Kobayashi et al., 1994; Albo
et al., 1995; Elton et al., 1999) and three regions of NP (aa
1–161, aa 255–340 and aa 340–465) were found to interact
independently with PB2 (Li et al., 2009; Ng et al., 2012).
Inﬂuenza viruses that cause severe infections are able to es-
cape to neutralizing antibodies following the accumulation of
mutations ‘‘antigenic drift’’ in their surface glycoproteins
(HA) and also by the introduction of mutations in the con-
served epitopes of viral proteins including NP and M1 (Ep-
stein, 2003). The nucleoprotein includes the best preserved
epitopes and appears to be the major target for the cytotoxic
T lymphocytes response (CTL), which limits the replication
of inﬂuenza virus and thus prevent the morbidity and mortal-
ity (Varich et al., 2009; Wahl et al., 2009). In humans, the anti-
genic peptides of viral nucleoprotein presented by infected cells
are essential for binding to HLA (human leucocyte antigen)
molecules class I of major histocompatibility complex
(MHC) and speciﬁc CTL of the CD8+ phenotype cross-reac-
tive for all type inﬂuenza A viruses (Taylor and Askonas,
1986; Voeten et al., 2000).
Four NP epitopes of inﬂuenza A virus were analyzed and
identiﬁed by several studies. They are in the form of shortsequences recognized by cytotoxic T lymphocytes: aa 265–
273, aa 338–347, aa 380–388 and aa 383–391 (Huet et al.,
1990; DiBrino et al., 1993; Voeten et al., 2000)
Phylogenetic analysis of the NP gene sequences of inﬂu-
enza A virus indicates that the NP gene is highly conserved
within the host-speciﬁc lineages (Thippamom et al., 2010)
and has been shown to be a major determinant of host spec-
iﬁcity (Shu etal., 1993). Eight distinct lineages were identiﬁed,
including the human lineage, porcine, avian and equine (Xu
et al., 2011).
In this paper, we studied the sequence of the nucleoprotein
(NP) of the four previously described CTL epitopes (Equine
Leucocyte Antigen (ELA)) of the equine inﬂuenza virus
A/equine/Nador/1/1997, which was isolated on 31 December
1997 in a mule with severe respiratory signs (cough, nasal
discharge, hyperthermia) in Nador in the north of Morocco.
Materials and methods
Viruses
A/equine/Nador/1/97 was isolated in Nador from a mule using
11-day-old speciﬁc-pathogen-free chicken eggs as described by
Kissi (Kissi et al., 1998).
Viral RNA extraction and ampliﬁcation
Viral RNAwas directly extracted from isolates using a Purelink
viral RNA/DNA-Minikit (Life Technologies) following the
manufacturer’s recommended protocol. cDNA was obtained
by reverse transcription reactions by using the Superscript III
Reverse transcriptase kit (Invitrogen, UK). PCR was
performed by Platinum PCR SuperMix High Fidelity kit
(Invitrogen, UK) on obtained cDNA using primer speciﬁc
NPF (ATGGCGTCTCAAGGCACCAAA) and NPR
(TTAACTGTCAAACTCCTCAGC) at a ﬁnal concentration
of 0.5 lM for primers. Primer design is detailed by Muller
et al., 2005. The thermal cycler was programmed as: incubation
at 95 C for 2 min, and then 35 cycles of denaturation at 95 C
for 30 s, 52 C for 1 min for hybridization, 72 C for 30 s.
Sequencing NP genes and phylogenetic analysis
The ampliﬁed PCR products were sequenced. Brieﬂy, the PCR
products were puriﬁed using EXOSAP-IT (USB) and bidirec-
tionally sequenced by using ABI BigDye1 Terminator v3.1
(Applied Biosystems) on an ABI 3130xl sequencer (Applied
Biosystems). Analysis of the produced electrophrogram was
carried out with the sequencing Analysis Software version
5.3.1 (Applied Biosystems).
Phylogenetic analysis was performed on thirty virus inﬂu-
enza strains isolated from different animals (Human, Avian,
equine, swine) (including Moroccan isolate) published in Gen-
Bank using the Neighbor Joining method (Saitou and Nei,
1987) in which the A/equine/Prague/1957 sequence was used
166 M. Boukharta et al.as the root. The tree was visualized using the MEGA5.1
software (Tamura et al., 2007).
Results and discussion
Partial sequencing of NP gene for inﬂuenza A (H3N8) viruses
isolated in Nador in 1997 was performed. Partial NP nucleo-
tide sequences of the Moroccan equine inﬂuenza isolate A/
equine/Nador/1/1997 was submitted to GenBank under acces-
sion number JQ955608. Phylogenetic analysis of the NP gene
showed that Moroccan isolate is belonging to equine host-spe-
ciﬁc lineage ‘‘recent equine’’ (Xu et al., 2011). Within this line-
age, the strain A/equine/Nador/1/1997 was more closely
related to Italian strains A/equine/Rome/5/1991 and
A/equine/Italy/1062/1991 (Fig. 1).Fig. 1 Phylogenetic relationships of nucleoprotein genes from 30
Victoria/1985, ABS89358; A/dunlin/Sweden/1/2005, ADQ20617; A
ACZ46635; A/duck/Manitoba/1/1953, AAA52234; A/gadwall/Ohio
swine/Belgium/WVL1/1979, ACO24984; A/swine/Germany/SEk1178/
Swine/Italy/1523/98,CAC40064; A/swine/Ploufragan/0214/2006, AFR
29759/1991, ACA24649; A/equine/Ohio/1/2003, AAZ23583; A/equ
ACA96815; A/equine/Berlin/1/1989, ACD85411; A/equine/Nador/1/1
Rome/5/1991, ACD85345; A/Aichi/198/2009, ACY39802;A/Amman/W
ADM32978; A/Antwerp/INS221/2009, ADK32641; A/Andalucia/GP
Prague/1956, AAA43108.The amino acid sequences of the nucleoprotein of the
strain A/equine/Nador/1/1997, compared to the reference
strain A/equine/ Miami/1/1963 represent twelve mutations
(12) in the residues T/284/A, A/286/T, R/293/K, I/299/V,
V/312/I, N/319/K, S/344/L, V/353/I, M/374/I, C/377/N,
N/397/S and R/452/K (Fig. 2). All of these substitutions
were carried on the interaction domains NP–NP and NP–
PB2. The study of the evolution of the human inﬂuenza
virus nucleoprotein gene from the earliest isolates to 1990
shows that substitutions such as A/286/T, R/293/K, S/344/
L, V/353/I and R/452/K were also affecting the human line-
age (Shu et al., 1993).
By analogy, these mutations are considered a kind of opti-
mal adaptation of equine inﬂuenza viruses within the lineage
«recent equine». Like human and swine lineage, the lineageinﬂuenza viruses. A/duck/Victoria/1992, ACZ46625; A/starling/
/duck/Rugen/79-6/1981, AFJ12908; A/duck/Alberta/286/1978,
/37/1999, ABI95177; A/swine/Germany/2/1981, AAA43667; A/
2000, CAP49194; A/swine/France/WVL13/1995, ACO25027; A/
76768; A/equine/Miami/1/1963, AAA43106; A/equine/Alaska/
ine/Athens/04/2007, ADT80589; A/equine/California/8560/2002,
997, AFJ69904; A/equine/Italy/1062/1991, ACD85356; A/equine/
RAIR1339 N/2009, ADM32950; A/Ankara/WRAIR1425T/2009,
251/2009, ACT67136; A/Texas/05/2009, ACU13087; A/equine/
Fig. 2 The amino acid sequence of the nucleoprotein (aa 260–454) of 30 equine inﬂuenza viruses (H3N8). CTL epitopes are framed.
Green line: CAS, red line: tail loup A/equine/Miami/1/1963, AAA43106; A/equine/Nador/1/1997, AFJ69904; A/equine/Algiers/1/1972,
ACF22130; A/equine/Berlin/1/1989, ACD85411; A/equine/California/4537/1997, ACA96804; A/equine/Cordoba/18/1985, ACD85279;
A/equine/Fontainbleu/1/1979, ACD85400; A/equine/Gansu/7/2008, ACE81939; A/equine/Georgia/1/1981, ABY81529; A/equine/Italy/
1199/1992, ACD85312; A/equine/Jilin/1/1989,AAA52247; A/equine/Johannesburg/1/1986, ACF22141; A/equine/Kentucky/1/1992,
ACA24638; A/equine/Kentucky/5/2002, AAX23576; A/equine/Kentucky/8/1994, ACA24682; A/equine/Liaoning/9/2008, ACE81906;
A/equine/Newmarket/1/1993, ACI48794; A/equine/Newmarket/2/1993, ACI48784; A/equine/Newmarket/5/2003, ACI48805; A/equine/
Ohio/1/2003, AAZ23583; A/equine/Qinghai/1/1994, ACE81884; A/equine/Romania/1/1980, ACD85378; A/equine/Rome/5/1991,
ACD85345; A/equine/Rook/93753/1989, ACD97440; A/equine/Santa Fe/1/1985 ACD85290; A/equine/Santiago/1/1985 AAQ90289; A/
equine/Sussex/1/1989, ACD97429; A/equine/Texas/39655/1991, ACA24627; A/equine/Uruguay/1/1963, ACD85422; A/equine/Wiscon-
sin/1/03, ABB17175.
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It is noteworthy to mention that the rate of mutation of mam-
malian inﬂuenza virus nucleoprotein is much higher than for
avian inﬂuenza viruses.
The N319 K mutation improves the interaction NP-PB2
and the polymerase activity in mammalian infected cells
(Gabriel et al., 2008). This was approved by the virulence of
the strain A/equine/Nador/1/1997 in the nature.
The thirty aligned sequences of equine inﬂuenza viruses
showed no mutation at the ﬁrst ILRGSVAHK epitope (aa
265–273) and proved to be conserved (Voeten et al., 2000).
Only one mutation I/265/V (ADC34563 A/equine/Huabei/1/
2007) was found in this epitope out of the 102 equine inﬂuenza
viruses available at Genbank (data not shown).
Equine Leucocyte Antigen (ELA) epitope FEDLRVSNFI
(aa 338–347) has the mutation (S/344/L), which is common
in several equine inﬂuenza viruses and one rare mutation in
residues N/345/S was found in the A/equine/Jilin/1/1989(AAA522479), this strain caused two severe outbreaks in
China, one was in 1989 which was shown to be more closely
related to avian H3N8 inﬂuenza virus (Guo et al., 1995).
In this second epitope, the substitution S/344/L of
A/equine/Nador/1/1997 strain also presents in cytoplasmic
accumulation signal (CAS), (residues 327–345), which had
integrated with F-actin and causes cytoplasmic retention of
the NP towards the end of infection (Portela and Digard,
2002). This mutation appears to facilitate the migration of
NP to the cytoplasm and consequently the viral cycle.
In the last two epitopes aa 380–388 and aa 383–391, we saw
a frequent mutation in several equine inﬂuenza viruses at res-
idue 384 (R/384/K) and only one mutation R/391/K of A/
equine/Kentucky/8/1994 (ACA24682). The R384 K mutation
seems to abrogate MHC class I presentation and recognition
by speciﬁc CTLs (Voeten et al., 2000).
The crystalian structure of the nucleoprotein showed that
each NP contains a ‘‘tail loup’’ formed by residues 402–428
168 M. Boukharta et al.(Li et al., 2009). As shown in Fig. 2, this sequence was con-
served among the studied strains.
Conclusion
The identiﬁed mutations were grouped into two categories, one
includes residues that facilitate the adaptation and evolution of
inﬂuenza viruses within the equine lineage such as A/286/T, R/
293/K, S/344/L, V/353/I and R/452/K, while the other con-
tained the substitutions which enhance the virulence such as
polymerase activity (N319 K) and mutations that affect CTL
epitopes, resulting in the escape from immune surveillance by
speciﬁc CTLs (S/344/L).
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